Table 2.
Demographic, functional and social patient characteristics obtained from the medical records.
| Group 1 (surprised if dead), n = 191 | Group 2a (not surprised if dead and not if alive), n = 105 | Group 2b (surprised if alive), n = 83 | All patients, n = 379 | |
|---|---|---|---|---|
| Age; mean (SD) | 56 (15) | 65 (13) | 61 (13) | 59 (15) |
| Gender | ||||
| Female; N (%) | 81 (42.4) | 46 (43.8) | 41 (49.4) | 168 (44.3) |
| Type of cancer; N (%) | ||||
| Skin | 37 (19.4) | 23 (21.9) | 16 (19.3) | 76 (20.1) |
| Digestive organs | 18 (9.4) | 18 (17.1) | 22 (26.5) | 58 (15.3) |
| Breast | 29 (15.2) | 10 (9.5) | 11 (13.3) | 50 (13.2) |
| Urinary tract | 18 (9.4) | 22 (21.0) | 10 (12.0) | 50 (13.2) |
| Male genital organs | 36 (18.8) | 6 (5.7) | 3 (3.6) | 45 (11.9) |
| Bone and soft tissue | 13 (6.8) | 2 (1.9) | 9 (10.8) | 24 (6.3) |
| Female genital organs | 9 (4.7) | 5 (4.8) | 5 (6.0) | 19 (5.0) |
| Central nervous system | 6 (3.1) | 8 (7.6) | 4 (4.8) | 18 (4.7) |
| More than one cancer | 10 (5.2) | 8 (7.6) | 0 (0.0) | 18 (4.7) |
| Head and neck | 11 (5.8) | 2 (1.9) | 3 (3.6) | 16 (4.2) |
| Endocrine glands | 3 (1.6) | 0 (0.0) | 0 (0.0) | 3 (0.8) |
| Blood, bone marrow and lymph nodes | 1 (0.5) | 0 (0.0) | 0 (0.0) | 1 (0.3) |
| Unknown primary site | 0 (0.0) | 1 (1.0) | 0 (0.0) | 1 (0.3) |
| Lower respiratory system | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
SD: standard deviation; N: number.